Search
Search
Bethyl Laboratories
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Carboxymethyl-lysine (CML) is a modified amino acid derivative that is formed during the Maillard reaction, a chemical reaction between amino acids and reducing sugars. Structurally, CML is formed by the addition of a carboxymethyl group to the lysine residue in proteins. The purpose of studying CML lies in its potential role as a biomarker for oxidative stress and the development of chronic diseases, such as diabetes, cardiovascular diseases, and aging-related conditions. Additionally, CML has been implicated in the pathogenesis of diabetic complications, such as nephropathy and retinopathy.
仅用于科研。不用于诊断过程。未经明确授权不得转售。